Neurology: Neuroimmunology and NeuroInflammation
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 8.0 | Q1 | 94.6% | 2.400 | Q1 | 96.6% |
| 2024 | 7.5 | Q1 | 93.7% | 3.008 | Q1 | 97.7% |
| 2023 | 7.8 | Q1 | 93.6% | 2.665 | Q1 | 97.3% |
| 2022 | 8.8 | Q1 | 93.5% | 2.288 | Q1 | 96.6% |
| 2021 | 11.4 | Q1 | 95.9% | 2.453 | Q1 | 97.2% |
| 2020 | — | — | 1.451 | Q1 | 92.0% | |
| 2019 | — | — | 1.674 | Q1 | 93.9% | |
| 2018 | — | — | 2.102 | Q1 | 95.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2332-7812
region
Northern America
coverage
2014-2026
